A Study to Investigate the Association of Real-world Sensor-derived Biometric Data With Clinical Parameters and Patient-reported Outcomes for Monitoring Disease Activity in Patients With COPD - Trial NCT05655832
Access comprehensive clinical trial information for NCT05655832 through Pure Global AI's free database. This phase not specified trial is sponsored by Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany and is currently Recruiting. The study focuses on Pulmonary Disease, Chronic Obstructive. Target enrollment is 77 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Timeline & Enrollment
N/A
Dec 05, 2022
Jun 30, 2023
Primary Outcome
Occurrence of COPD exacerbations,Severity of exacerbations
Summary
The purpose of this multicenter, prospective cohort study is to investigate the correlation
 of real-world sensor-derived biometric data obtained via a wearable device with clinical
 parameters and patient-reported outcomes (PROs) for monitoring disease activity and
 predicting exacerbations for participants with Chronic Obstructive Pulmonary Disease (COPD).
 The cohort of participants with COPD will be followed for 3 months. A calibration cohort with
 non-COPD participants will be included and followed for 2 weeks.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05655832
Device Trial